Concepedia
Statistics
Publications
15
Citations
701
H-Index
12
Active since
2014
Affiliations
University of Leeds(Current)
Max Planck Institute of Molecular Physiology
TU Dortmund University
Ruhr University Bochum
Institute of Structural and Molecular Biology
George Karageorgis is an author at University of Leeds specializing in drug design, drug discovery, and medicinal chemistry.
Publications per year
2014–2024
Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth
Elena S. Reckzeh, George Karageorgis, Melanie Schwalfenberg et al. · Cell chemical biology · 2019 · 160 citations · Full text
Medicine, Cancer Biology, Oncology +12
Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3
George Karageorgis, Elena S. Reckzeh, Javier Ceballos et al. · Nature Chemistry · 2018 · 116 citations
Medicine, Medicinal Chemistry, Pharmacology +10
Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3
Javier Ceballos, Melanie Schwalfenberg, George Karageorgis et al. · Angewandte Chemie International Edition · 2019 · 100 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Efficient discovery of bioactive scaffolds by activity-directed synthesis
George Karageorgis, Stuart L. Warriner, Adam Nelson · Nature Chemistry · 2014 · 65 citations
Pharmacy, Medicinal Chemistry, Pharmacology +16
The Pseudo Natural Product Myokinasib Is a Myosin Light Chain Kinase 1 Inhibitor with Unprecedented Chemotype
Tabea Schneidewind, Shobhna Kapoor, Guillaume Garivet et al. · Cell chemical biology · 2019 · 56 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +9
1–5 of 15